Inicio › Enfermedad de Alzheimer › Arizona
Ensayos clínicos de Enfermedad de Alzheimer en Arizona
23 estudios sobre Enfermedad de Alzheimer buscan participantes en Arizona.
Ciudades en Arizona
Texto oficial del estudio (inglés)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Phoenix
- Clinical Site, Scottsdale
- Clinical Site, Tucson
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2609, Chandler
- Imaging Endpoints, Scottsdale
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06937229A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- TrialSphere Corp, Chandler
- HonorHealth Research Institute, Scottsdale
ReclutandoFase 2
Edades de 55 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Gilbert Neurology Partners - PLLC - Avacare, Gilbert
- Banner Alzheimer's Institute, Phoenix
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Banner Alzheimer's Institute, Phoenix
- Barrow Neurological Institute, Phoenix
- Clinical Endpoints, Scottsdale
ReclutandoFase 2
Edades de 55 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Banner Alzheimer?s Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Chandler Clinical Trials, LLC, Chandler
- Local Institution - 2631, Chandler
- TrialSphere Corp, Chandler
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Imaging Endpoints, Scottsdale
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011732Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0040, Scottsdale
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06808984A Study of AMDX-2011P in Participants With Alzheimer's Disease
- Associated Retina Consultants, Phoenix
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT06514001The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- University of Arizona, Tucson
Reclutando
Edades de 55 a 85 · Todos los sexos · Actualizado el 6 ago 2026 · NCT05988385Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Arizona State University, Phoenix
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 65 · Todos los sexos · Actualizado el 17 jul 2026 · NCT05980052A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Banner Alzheimer's Institute, Phoenix
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Gilbert Neurology Partners/CCT Research, Gilbert
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 jun 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Banner Alzheimers Institute, Phoenix
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 jun 2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Barrow Neurological Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
ReclutandoFase 3
Edades de 50 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Barrow Neurological Institute, Phoenix
ReclutandoEstudio observacional
Edades de 25 a 55 · Todos los sexos · Actualizado el 18 may 2026 · NCT04165109A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
- Arizona State University, Phoenix
ReclutandoSe aceptan voluntarios sanos
Edades de 65 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT05877196Early-Stage Partner in Care Living Alone Plus
- Arizona State University, Phoenix
Reclutando
Edades de 60 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT06962111Repurposing Siponimod for Alzheimer's Disease
- St. Joseph's Hospital and Medical Center, Phoenix
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 4 mar 2026 · NCT06639282A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
- Mayo Clinic Arizona, Scottsdale
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 50 a 95 · Todos los sexos · Actualizado el 3 feb 2026 · NCT06057909Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Banner Alzheimer's Institute, Phoenix
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 110 · Todos los sexos · Actualizado el 16 dic 2025 · NCT02022943PROMIS and Mobility Evaluation in Sarcoma Patients
- Mayo Clinic, Phoenix
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2025 · NCT07227961De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.